Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Laing distal myopathy with a novel mutation in exon 34 of the MYH7 gene.

Ferbert A, Zibat A, Rautenstrauß B, Kress W, Hügens-Penzel M, Weis J, Shah Y, Roth C.

Neuromuscul Disord. 2016 Sep;26(9):598-603. doi: 10.1016/j.nmd.2016.06.458. Epub 2016 Jun 22.

PMID:
27469267
2.

Inactivation of Patched1 in mice leads to development of gastrointestinal stromal-like tumors that express Pdgfrα but not kit.

Pelczar P, Zibat A, van Dop WA, Heijmans J, Bleckmann A, Gruber W, Nitzki F, Uhmann A, Guijarro MV, Hernando E, Dittmann K, Wienands J, Dressel R, Wojnowski L, Binder C, Taguchi T, Beissbarth T, Hogendoorn PC, Antonescu CR, Rubin BP, Schulz-Schaeffer W, Aberger F, van den Brink GR, Hahn H.

Gastroenterology. 2013 Jan;144(1):134-144.e6. doi: 10.1053/j.gastro.2012.09.061. Epub 2012 Oct 3.

3.

Uncommitted precursor cells might contribute to increased incidence of embryonal rhabdomyosarcoma in heterozygous Patched1-mutant mice.

Nitzki F, Zibat A, Frommhold A, Schneider A, Schulz-Schaeffer W, Braun T, Hahn H.

Oncogene. 2011 Oct 27;30(43):4428-36. doi: 10.1038/onc.2011.157. Epub 2011 May 23.

PMID:
21602886
4.

Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma.

Zibat A, Missiaglia E, Rosenberger A, Pritchard-Jones K, Shipley J, Hahn H, Fulda S.

Oncogene. 2010 Dec 2;29(48):6323-30. doi: 10.1038/onc.2010.368. Epub 2010 Sep 6.

PMID:
20818440
5.

Evaluating the effect of spastin splice mutations by quantitative allele-specific expression assay.

Klimpe S, Zibat A, Zechner U, Wellek B, Shoukier M, Sauter SM, Pantakani DV, Mannan AU.

Eur J Neurol. 2011 Jan;18(1):99-105. doi: 10.1111/j.1468-1331.2010.03079.x.

PMID:
20491894
6.

Tumor stroma-derived Wnt5a induces differentiation of basal cell carcinoma of Ptch-mutant mice via CaMKII.

Nitzki F, Zibat A, König S, Wijgerde M, Rosenberger A, Brembeck FH, Carstens PO, Frommhold A, Uhmann A, Klingler S, Reifenberger J, Pukrop T, Aberger F, Schulz-Schaeffer W, Hahn H.

Cancer Res. 2010 Apr 1;70(7):2739-48. doi: 10.1158/0008-5472.CAN-09-3743. Epub 2010 Mar 16.

7.

Time-point and dosage of gene inactivation determine the tumor spectrum in conditional Ptch knockouts.

Zibat A, Uhmann A, Nitzki F, Wijgerde M, Frommhold A, Heller T, Armstrong V, Wojnowski L, Quintanilla-Martinez L, Reifenberger J, Schulz-Schaeffer W, Hahn H.

Carcinogenesis. 2009 Jun;30(6):918-26. doi: 10.1093/carcin/bgp068. Epub 2009 Mar 25.

PMID:
19321799
8.

Rapid access to genes of biotechnologically useful enzymes by partial genome sequencing: the thermoalkaliphile Anaerobranca gottschalkii.

Antranikian G, Ruepp A, Gordon PM, Ballschmiter M, Zibat A, Stark M, Sensen CW, Frishman D, Liebl W, Klenk HP.

J Mol Microbiol Biotechnol. 2009;16(1-2):81-90. doi: 10.1159/000142896. Epub 2008 Oct 29.

PMID:
18957864
9.

The Hedgehog receptor Patched controls lymphoid lineage commitment.

Uhmann A, Dittmann K, Nitzki F, Dressel R, Koleva M, Frommhold A, Zibat A, Binder C, Adham I, Nitsche M, Heller T, Armstrong V, Schulz-Schaeffer W, Wienands J, Hahn H.

Blood. 2007 Sep 15;110(6):1814-23. Epub 2007 May 29.

PMID:
17536012
10.

The genome of Hyperthermus butylicus: a sulfur-reducing, peptide fermenting, neutrophilic Crenarchaeote growing up to 108 degrees C.

Brügger K, Chen L, Stark M, Zibat A, Redder P, Ruepp A, Awayez M, She Q, Garrett RA, Klenk HP.

Archaea. 2007 May;2(2):127-35.

11.

The genome of Sulfolobus acidocaldarius, a model organism of the Crenarchaeota.

Chen L, Brügger K, Skovgaard M, Redder P, She Q, Torarinsson E, Greve B, Awayez M, Zibat A, Klenk HP, Garrett RA.

J Bacteriol. 2005 Jul;187(14):4992-9.

12.

The genome of Desulfotalea psychrophila, a sulfate-reducing bacterium from permanently cold Arctic sediments.

Rabus R, Ruepp A, Frickey T, Rattei T, Fartmann B, Stark M, Bauer M, Zibat A, Lombardot T, Becker I, Amann J, Gellner K, Teeling H, Leuschner WD, Glöckner FO, Lupas AN, Amann R, Klenk HP.

Environ Microbiol. 2004 Sep;6(9):887-902.

PMID:
15305914
13.

Multiple novel nonsynonymous CYP2B6 gene polymorphisms in Caucasians: demonstration of phenotypic null alleles.

Lang T, Klein K, Richter T, Zibat A, Kerb R, Eichelbaum M, Schwab M, Zanger UM.

J Pharmacol Exp Ther. 2004 Oct;311(1):34-43. Epub 2004 Jun 9.

PMID:
15190123
14.

Reconstruction of the central carbohydrate metabolism of Thermoproteus tenax by use of genomic and biochemical data.

Siebers B, Tjaden B, Michalke K, Dörr C, Ahmed H, Zaparty M, Gordon P, Sensen CW, Zibat A, Klenk HP, Schuster SC, Hensel R.

J Bacteriol. 2004 Apr;186(7):2179-94.

15.

The genetic determinants of the CYP3A5 polymorphism.

Hustert E, Haberl M, Burk O, Wolbold R, He YQ, Klein K, Nuessler AC, Neuhaus P, Klattig J, Eiselt R, Koch I, Zibat A, Brockmöller J, Halpert JR, Zanger UM, Wojnowski L.

Pharmacogenetics. 2001 Dec;11(9):773-9.

PMID:
11740341
16.

Efficient transformation of Halobacterium salinarum by a "freeze and thaw" technique.

Zibat A.

Biotechniques. 2001 Nov;31(5):1010, 1012. No abstract available.

17.

Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4.

Hustert E, Zibat A, Presecan-Siedel E, Eiselt R, Mueller R, Fuss C, Brehm I, Brinkmann U, Eichelbaum M, Wojnowski L, Burk O.

Drug Metab Dispos. 2001 Nov;29(11):1454-9.

PMID:
11602521
18.

Identification and functional characterization of eight CYP3A4 protein variants.

Eiselt R, Domanski TL, Zibat A, Mueller R, Presecan-Siedel E, Hustert E, Zanger UM, Brockmoller J, Klenk HP, Meyer UA, Khan KK, He YA, Halpert JR, Wojnowski L.

Pharmacogenetics. 2001 Jul;11(5):447-58.

PMID:
11470997
19.

Supplemental Content

Support Center